Cancer treatment with combination of EP4 antagonist and immune checkpoint inhibitor

TW202637120APending Publication Date: 2026-09-16ONO PHARMA CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW115115387
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2021-01-20
Filing Date
2021-11-12
Publication Date
2026-09-16

Smart Images

  • Figure TWG2TA001077369_001
    Figure TWG2TA001077369_001
  • Figure TWG2TA001077369_002
    Figure TWG2TA001077369_002
  • Figure TWG2TA001077369_003
    Figure TWG2TA001077369_003
Patent Text Reader

Abstract

An objective of the present invention is to provide an effective method for cancer treatment. The method for cancer treatment provided in the present invention combines standard treatments, EP4 antagonist, and an immune checkpoint inhibitor (e.g., an anti-PD-1 antibody, or the like). The treatment method of the present invention is useful for cancer treatment.
Need to check novelty before this filing date? Find Prior Art